A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer.
Shuangshuang LuZhe ZhangPan DuLouisa S ChardWenli YanMargueritte El KhouriZhizhong WangZhongxian ZhangYongchao ChuDongling GaoQinxian ZhangLirong ZhangAi NaganoJun WangClaude ChelalaJing LiuJiekai ChenPentao LiuChunguang QiuShengdian WangXiaozhu LiNicholas R LemoineDuanqing PeiYaohe WangPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
These results provide both proof of concept and a robust technology platform for the development of personalized prophylactic cancer vaccines to prevent pancreatic malignancies in at-risk individuals.